BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mary Ann Liebert, Inc. Release: Novel Treatments In Development For Alzheimer's Disease Will Highlight Fourth Annual Conference On Regenerative Medicine


10/19/2005 5:10:15 PM

LARCHMONT, N.Y.--(BUSINESS WIRE)--Nov. 4, 2003--Innovative treatment strategies in development for combating Alzheimer's disease and related neurodegenerative disorders will be the focus of a lively and informative session entitled "Exploring New Frontiers in Alzheimer's Disease" at the Fourth Annual Conference on Regenerative Medicine, November 17-19, 2003, in Washington, D.C. "Rebuilding the Body, Restoring Function," is the focus of this year's conference, which is jointly sponsored by Genetic Engineering News, a publication of Mary Ann Liebert, Inc. (www.liebertpub.com), the University of South Florida College of Medicine, and the Regenerative Medicine and Stem Cell Biology Society, and is presented by BioConferences International. The complete program including summaries of the presentations can be viewed at www.bioconferences.com/ebio

Session Chair Michael Wolfe, Ph.D., Associate Professor at Harvard Medical School/Brigham and Women's Hospital, has gathered a forward-thinking group of speakers on cutting-edge research at major research institutions on the cause of Alzheimer's disease and on drug, gene, and vaccine therapies aimed at preventing, curing, and slowing the progression of the brain pathology and cognitive decline that is characteristic of this disorder.

John Hardy, Ph.D., of the National Institute on Aging will discuss the role amyloid beta protein plays in the initiation of Alzheimer's disease in his talk, "Subtle Differences in Protein Quantity Underlie Initiation of Neurodegenerative Diseases." A key challenge in treating diseases affecting the central nervous system is developing therapies that are able to cross the blood-brain barrier. William Pardridge, M.D., Professor of Medicine at the University of California, Los Angeles, will present on "Drug and Gene Delivery to the Brain: The Trans-Vascular Route."

Therapeutic vaccines that stimulate the immune system to target and destroy amyloid beta protein have shown promise in preclinical testing. Cynthia Lemere, Ph.D., Assistant Professor at Harvard Medical School provides an up-to-date look at "Beta Amyloid Immunization Therapy." Michael Wolfe explores novel drug targets in a presentation entitled "Secretase Targets for Alzheimer's Disease."

World-class scientists from leading academic centers, industry, and government research institutions will also present their most recent findings during conference sessions that will focus on Cellular Therapies: Repairing the Damaged and Worn Body, Substitutive Medicine: Organ Replacement and Repair, and Tissue Engineering.

Robert Langer, Ph.D. (MIT), will present the Keynote Address, entitled "Novel Biomaterials." In the New Ventures Address, Linda Powers, Managing Director of Toucan Capital, will provide a detailed overview of the current economic environment and discuss the opportunities and obstacles for early-stage funding.

For more information about the Fourth Annual Conference on Regenerative Medicine, including registration, submitting a poster abstract, sponsorships, and exhibits, please contact hmatysko@liebertpub.com, (800) 5-BIOCON, (914) 834-3100, ext. 608, fax (914) 834-3689.

Contact:

Mary Ann Liebert, Larchmont Harriet Matysko, 914-834-3100, ext. 608

Source: Mary Ann Liebert



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->